Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£129.64	199.81%	£209,870.48
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£129.64	181.03%	£196,722.30
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£14,774.00	22.87%	£86,009.65
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£14,774.00	258.94%	£251,258.50
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£14,774.00	281.12%	£266,781.89
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£14,774.00	99.06%	£139,339.80
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£14,774.00	25.48%	£87,835.91
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£14,774.00	454.06%	£387,841.74
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£14,774.00	21.54%	£85,075.68
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£14,774.00	172.73%	£190,913.79
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£14,774.00	23.90%	£86,730.96
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£14,774.00	44.42%	£101,092.86
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£14,774.00	84.56%	£129,191.76
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£14,774.00	402.86%	£352,001.36
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.71	-78.52%	£15,036.25
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£55.27	47.82%	£103,474.19
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£55.27	3.44%	£72,410.63
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£55.27	29.20%	£90,437.12
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£55.27	40.35%	£98,245.30
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£55.27	30.63%	£91,441.74
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£55.27	39.96%	£97,971.63
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£55.27	23.51%	£86,455.87
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£55.27	25.56%	£87,889.60
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£55.27	47.90%	£103,529.57
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£239.63	45.20%	£101,642.73
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£239.63	95.39%	£136,775.12
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£239.63	229.66%	£230,762.14
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£239.63	293.29%	£275,301.17
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£239.63	48.18%	£103,723.10
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£202.00	179.96%	£195,969.03
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£202.00	-18.84%	£56,813.85
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£288.77	14.04%	£79,827.42
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£288.77	-41.07%	£41,247.80
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£288.77	-46.31%	£37,584.18
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£288.77	-44.27%	£39,007.91
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£288.77	-51.42%	£34,007.23
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,261.21	87.54%	£131,280.31
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£518.84	24.08%	£86,857.99
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£518.84	12.98%	£79,084.58
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£518.84	-11.10%	£62,228.09
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£518.84	12.05%	£78,435.56
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£518.84	8.68%	£76,074.66
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£124.00	-79.76%	£14,169.12
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£124.00	-61.25%	£27,125.00
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£39.07	7.48%	£75,237.97
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£39.07	-61.58%	£26,894.48
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£39.07	-68.17%	£22,280.24
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£39.07	-70.99%	£20,309.67
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£122.23	-27.29%	£50,898.87
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£122.23	-24.93%	£52,549.44
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£161.01	82.18%	£127,525.46
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£161.01	143.78%	£170,643.07
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£161.01	197.94%	£208,557.47
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£190.00	-16.48%	£58,461.54
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£351.50	39.57%	£97,697.04
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£351.50	13.52%	£79,460.68
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£351.50	37.41%	£96,188.43
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£351.50	16.01%	£81,204.62
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£351.50	13.75%	£79,627.83
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£111.04	339.48%	£307,635.46
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£111.04	2.04%	£71,428.05
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£111.04	237.51%	£236,255.31
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.68	-84.51%	£10,845.85
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.61	36.15%	£95,305.14
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.61	-8.31%	£64,180.64
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£34.85	54.17%	£107,918.40
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£34.85	66.11%	£116,275.23
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£315.59	262.37%	£253,660.59
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£370.50	433.71%	£373,595.52
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£370.50	34.73%	£94,309.09
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.40	-5.02%	£66,485.36
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.40	-17.38%	£57,834.40
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£15.86	23.81%	£86,666.66
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£93.01	-7.70%	£64,609.51
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£78.69	-0.94%	£69,339.12
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£37.78	-60.35%	£27,758.24
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£175.60	-35.85%	£44,902.28
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£232.35	44.49%	£101,141.10
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£496.70	78.77%	£125,135.87
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£496.70	41.59%	£99,116.28
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£496.70	-9.90%	£63,067.30
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£534.47	1,622.99%	£1,206,089.55
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£26.05	4.16%	£72,910.25
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,680.00	0.07%	£70,052.28
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£618.92	1,965.82%	£1,446,074.77
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£983.26	34.45%	£94,113.74
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,210.00	-40.28%	£41,806.52
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.22	-97.18%	£1,972.74
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£836.90	50.25%	£105,175.95
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£4.85	246.43%	£242,500.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.13	63.02%	£114,114.59
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.95	-8.75%	£63,875.00
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£29.03	92.89%	£135,023.26
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.18	-98.52%	£1,033.08
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£9.64	-9.23%	£63,540.49
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£7.00	-37.78%	£43,555.56
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£45.68	51.86%	£106,303.19
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£53.83	-51.93%	£33,649.76
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£381.20	13.42%	£79,393.04
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£7.14	-43.56%	£39,509.88
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£215.90	4.05%	£72,833.73
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£215.90	-20.97%	£55,318.44
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.57	-97.79%	£1,548.08
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£71.00	-36.61%	£44,375.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£71.00	37.86%	£96,504.85
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£114.36	554.61%	£458,225.56
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£4.19	-86.03%	£9,776.67
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.81	-3.54%	£67,518.99

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.